Skip to search formSkip to main contentSkip to account menu

m-BACOD Regimen

Known as: Methotrexate-Bleomycin-Adriamycin-Cytoxan-Oncovin-Decadron Regimen 
A regimen consisting of methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine and dexamethasone used to treat aggressive forms of non… 
National Institutes of Health

Related topics

Related topics

8 relations
BleomycinCyclophosphamideDexamethasoneDoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Adult non-Hodgkin's lymphoma.
  • I. Mehdi
  • JPMA. The Journal of the Pakistan Medical…
  • 1999
  • Corpus ID: 37028344
1998
1998
[Bleomycin, adriamycin, cyclophosphamide, vincristine, deacadron, etoposide (BACOD-E) chemotherapy for the treatment of non-Hodgkin's lymphoma: long-term survival rate and complications].
This study was performed to analyze the effect of Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, Deacadron, Etoposide… 
1996
1996
Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome‐related lymphoma: Effect on human…
Use of multiagent chemotherapy has been associated with complete remission (CR) in approximately 50% of patients with newly… 
1995
1995
[Methotrexate pneumonitis arising during the treatment of non-Hodgkin's lymphomas with the m-BACOD protocol].
We retrospectively studied 32 patients treated with the m-BACOD regimen in a single institution between January 1988 and December… 
1990
1990
[M-BACOD in advanced case of non-Hodgkin's lymphoma].
A M-BACOD regimen using an increased dose of Adriyamycin has been administered to 18 patients with non-Hodgkin's lymphoma. Sixty… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)